QuantLogix ← CL scorecard
📅 CL Earnings Preview
Colgate-Palmolive Company
Next report (est.)
10/30/2026
Countdown
2 days
EPS growth YoY
-5.5%
Revenue growth YoY
+4.9%
Options-implied earnings move
±3.6%
The at-the-money straddle prices a move to roughly $95.86 or $89.17 from $92.52 by 10/30/2026.
Implied vs actual — last 8 reports
ReportOptions impliedActual moveMarket was
07/31/2026 ±2.9% -0.3% over-priced
05/01/2026 ±1.8% +2.2% under-priced
02/23/2026 ±2.0% +2.1% under-priced
10/31/2025 ±1.6% +0.7% over-priced
08/01/2025 ±2.0% -0.4% over-priced
04/25/2025 ±2.6% +1.3% over-priced
02/13/2025 ±1.6% +1.2% over-priced
10/25/2024 ±1.3% -4.1% under-priced
Across these reports, options implied an average ±2.0% move vs an actual average of 1.6% — the stock stayed inside the implied band 63% of the time.
Fundamentals into the print
QuarterEPS (dil.)RevenueNet income
Q2 FY2026 $0.86 $5.4B $693M
Q1 FY2026 $0.80 $5.3B $646M
Q4 FY2025 — $5.2B $-36M
Q3 FY2025 $0.91 $5.1B $735M
Analyst posture
Buy / Strong Buy
20
Hold
10
Sell
0
Stable: +2 net change 30d
Live 5-factor engine read: Buy · 79/100 Full scorecard →
Get alerted before every CL report — free Full live analysis
🤖 Pro runs a 10-agent AI debate on CL before the print — 5 analysts, bull vs bear, a risk read, and a trader's verdict. See Pro →

Colgate-Palmolive Company (CL) reports in 2 days, with the next report estimated for 10/30/2026. Across the last 8 reports, options priced an average ±2.0% earnings move while the stock actually moved 1.6% on average — the market has been roughly fair on CL's earnings risk. Fundamentals into the print: EPS down 5.5% year-over-year, revenue up 4.9%. QuantLogix's live 5-factor engine currently reads CL as a buy at 79/100.

Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →